ストックスクリーナーアプリを入手
27.69
0.93%
0.255
前日終値:
$27.43
開ける：
$27.59
24時間の取引高:
9,348
Relative Volume:
0.05
時価総額：
$398.62M
収益：
$138.20M
当期純損益:
$5.52M
株価収益率:
72.87
EPS:
0.38
ネットキャッシュフロー:
$9.86M
1週間 パフォーマンス:
+0.84%
1か月 パフォーマンス:
-4.91%
6か月 パフォーマンス:
+0.18%
1年 パフォーマンス:
-26.42%
1日の値動き範囲:
$27.40
$27.89
1週間の範囲:
$26.73
$27.89
52週間の値動き範囲:
$26.00
$40.38
Surmodics Inc Stock (SRDX) Company Profile
SRDX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
27.88 | 392.26M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
122.67 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.22 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.39 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
89.16 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
80.47 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-07 | アップグレード | Lake Street | Hold → Buy |
| 2023-06-13 | アップグレード | Needham | Hold → Buy |
| 2023-02-13 | ダウングレード | Needham | Buy → Hold |
| 2020-07-23 | アップグレード | Needham | Hold → Buy |
| 2019-12-11 | ダウングレード | Needham | Buy → Hold |
| 2019-11-01 | ダウングレード | Lake Street | Buy → Hold |
| 2019-08-01 | 繰り返されました | Needham | Buy |
| 2019-05-02 | 繰り返されました | Lake Street | Buy |
| 2019-05-02 | 繰り返されました | Needham | Buy |
| 2019-02-21 | 繰り返されました | Needham | Buy |
| 2018-05-16 | 繰り返されました | Needham | Buy |
| 2018-03-01 | アップグレード | Sidoti | Neutral → Buy |
| 2018-02-28 | 繰り返されました | Lake Street | Buy |
| 2018-02-28 | 開始されました | Needham | Buy |
| 2017-07-14 | 開始されました | Lake Street | Buy |
| 2016-11-21 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2016-10-06 | ダウングレード | Sidoti | Buy → Neutral |
| 2016-05-03 | 繰り返されました | Barrington Research | Outperform |
| 2015-08-06 | 繰り返されました | Barrington Research | Outperform |
| 2015-03-27 | 開始されました | Dougherty & Company | Buy |
| 2014-02-25 | 開始されました | Laidlaw | Buy |
| 2013-08-01 | アップグレード | Feltl & Co. | Buy → Strong Buy |
| 2012-11-12 | 繰り返されました | Barrington Research | Outperform |
すべてを表示
Surmodics Inc (SRDX) 最新ニュース
Is it time to cut losses on Surmodics Inc.Portfolio Update Report & Fast Momentum Stock Entry Tips - newser.com
Surmodics to present updated data on Pounce thrombectomy system - Investing.com
Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3 - FinancialContent
Can Surmodics Inc. stock reach $100 price targetJuly 2025 News Drivers & Stock Market Timing Techniques - newser.com
Can Surmodics Inc. stock deliver sustainable ROEWeekly Trade Summary & AI Enhanced Trade Execution Alerts - newser.com
Is Surmodics Inc. stock resilient to inflationWeekly Market Outlook & Accurate Entry/Exit Alerts - newser.com
Will Surmodics Inc. stock return to pre crisis levelsWeekly Stock Recap & AI Powered Trade Plan Recommendations - newser.com
Is Surmodics Inc. stock a safe investment in uncertain markets2025 Stock Rankings & Free Real-Time Volume Trigger Notifications - newser.com
What earnings revisions data tells us about Surmodics Inc.Weekly Investment Report & Community Verified Swing Trade Signals - newser.com
How institutional ownership impacts Surmodics Inc. stock2025 Valuation Update & Risk Controlled Stock Pick Alerts - newser.com
Published on: 2025-11-01 01:11:15 - newser.com
Is Surmodics Inc. stock entering bullish territoryJuly 2025 Short Interest & Growth Focused Entry Reports - newser.com
Regression analysis insights on Surmodics Inc. performanceEarnings Beat & Proven Capital Preservation Methods - newser.com
Published on: 2025-10-31 04:30:06 - newser.com
Published on: 2025-10-31 04:03:38 - newser.com
Surmodics (SRDX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
How to interpret RSI for Surmodics Inc. stockJuly 2025 Closing Moves & Proven Capital Preservation Tips - newser.com
Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform - BioSpace
Surmodics (SRDX) PROWL Study Highlights Success in Thrombectomy Procedures - GuruFocus
Surmodics, Inc. (NASDAQ:SRDX) Given Average Rating of "Hold" by Analysts - MarketBeat
Published on: 2025-10-29 03:26:33 - fcp.pa.gov.br
Surmodics Announces PROWL Registry Sex-Specific Data to be Presented at TCT Conference on October 28 - BioSpace
Sectors Review: Will Surmodics Inc. stock reach all time highs in 2025Dip Buying & Free Community Consensus Stock Picks - fcp.pa.gov.br
Aug Chart Watch: Will Surmodics Inc. stock reach all time highs in 2025July 2025 Momentum & Safe Capital Growth Stock Tips - fcp.pa.gov.br
Published on: 2025-10-27 15:15:37 - Fundação Cultural do Pará
Surmodics' PROWL Registry data to unveil new clinical insights - Traders Union
Surmodics Inc (SRDX) 財務データ
収益
当期純利益
現金流量
EPS
0.69%
0.27%
大文字化:
|
ボリューム (24 時間):